Janus Henderson Group
IMGN

Janus Henderson Group’s Immunogen Inc IMGN Stock Holding History

Janus Henderson Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,043,986
Closed -$327M – 2600
2023
Q4 		$327M Sell
11,043,986
-6,640,830
-38% -$132M 0.2% 126
2023
Q3 		$281M Buy
17,684,816
+2,185,028
+14% +$36.3M 0.18% 137
2023
Q2 		$292M Sell
15,499,788
-950,293
-6% -$11.2M 0.18% 133
2023
Q1 		$63.2M Buy
16,450,081
+13,302,505
+423% +$56.7M 0.04% 330
2022
Q4 		$15.6M Buy
3,147,576
+526,592
+20% +$2.86M 0.01% 617
2022
Q3 		$12.5M Buy
2,620,984
+2,400,624
+1,089% +$12.7M ﹤0.01% 779
2022
Q2 		$993K Sell
220,360
-1,017,967
-82% -$4.42M ﹤0.01% 1331
2022
Q1 		$5.89M Buy
1,238,327
+814,464
+192% +$4.51M ﹤0.01% 980
2021
Q4 		$3.14M Buy
423,863
+404,198
+2,055% +$2.51M ﹤0.01% 1172
2021
Q3 		$112K Buy
+19,665
New +$114K ﹤0.01% 2140

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janus Henderson Group's IMGN Position: Q1 2024 in Review

Janus Henderson Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 11,043,986 shares — an estimated $327M sold.

Janus Henderson Group first reported a position in IMGN in Q3 2021 and held it in 10 quarters. The position peaked at $327M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Janus Henderson Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Janus Henderson Group sold 11,043,986 Immunogen Inc shares in Q1 2024, an estimated $327M.
  • Janus Henderson Group first reported a position in Immunogen Inc in Q3 2021 and held it in 10 quarters.
  • Janus Henderson Group's Immunogen Inc position peaked at $327M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.